Japan· JP-2129006F1050
プロパフェノン塩酸塩
A propafenone product containing プロパフェノン塩酸塩, registered in Japan by 大原薬品工業, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Propafenone is registered in 16 of 19 countries.
Countries holding a registration under ATC C01BC03 (propafenone), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Propafenone · ATC C01BC03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of propafenone costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.23 in France to $0.68 in United States — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Propafenone · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- US United States$0.68 (acquisition cost)
- IT Italy$0.45
- ES Spain$0.28
- FR France$0.23
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- プロパフェノン塩酸塩
- Manufacturer
- 大原薬品工業
- Country
- Japan (JP)
- ATC code
- C01BC03
- ATC class
- Propafenone
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
311 interactions on record for propafenone.
Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Propafenone · interactions on record
311 records
- 47 severe
- 192 moderate
- 7 minor
- 19 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01BC03
Propafenone, as other registers publish it.
- CanadaAPO-PROPAFENONEAPOTEX INC
- CanadaAPO-PROPAFENONEAPOTEX INC
- United KingdomArythmol 150mg tabletsDowelhurst Ltd
- United KingdomArythmol 150mg tabletsWaymade Healthcare Plc
- United KingdomArythmol 150mg tabletsMawdsley-Brooks & Company Ltd
- United KingdomArythmol 150mg tabletsViatris UK Healthcare Ltd
- United KingdomArythmol 150mg tabletsDE Pharmaceuticals
- United KingdomArythmol 300mg tabletsWaymade Healthcare Plc
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab445f95-198e-48c0-b1ce-b5faf6ee1239 GET /v1/drugs/ab445f95-198e-48c0-b1ce-b5faf6ee1239?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "150mg1錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2129006F1050",
"category": "内用薬",
"price_yen": 12.8,
"generic_name": "プロパフェノン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2129",
"transitional_expiry": null
}See everything about propafenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.